Activity of lytic peptides against intracellular Trypanosoma cruzi amastigotes in vitro and parasitemias in mice
Activity of lytic peptides against intracellular Trypanosoma cruzi amastigotes in vitro and parasitemias in mice
复制标题
DOI:
10.2307/3284051
复制
发表时间:
1995-12-01
影响因子:
1.3
通讯作者:
Jaynes, JM
中科院分区:
文献类型:
--
作者:
Barr, SC;Rose, D;Jaynes, JM
Three oecropin-like lytic peptides (DC-1, DC-2, and DC-2R) were synthesized with virtually no sequence homology with the natural compound (cecropin B) while retaining the charge distribution, amphipathic, and hydrophobic properties of the natural compound. A fourth analog (alpha-Pi) without these later properties, but a similar molecular weight, was also synthesized as a nonlytic peptide control. The 3 lytic peptides were examined for their ability to kill Trypanosoma cruzi trypomastigotes in vitro, intracellular amastigotes in vitro, and their toxicity to a mammalian cell line. DC-2 at 5 mu M and DC-1 and DC-2R at 10 mu M were 100% effective in killing T. cruzi trypomastigotes in vitro, suggesting at least a 10-fold increase in lytic activity over previous tested lytic peptide analogues, SB-37 and Shiva-1. When T. cruzi-infected Veto cells were treated with a single or double exposure of low concentrations (2.5 mu M) of DC-1, DC-2, and DC-2R there was a significant (P < 0.05) reduction in amastigote numbers/cell when compared to untreated and alpha-Pi-treated T. cruzi-infected cells. Vero cells alone treated with the lytic peptides showed no reduction in number or toxicity. One of the peptides (DC-1) was tested for its toxicity in GT mice and its ability to reduce parasitemias in T. cruzi-infected AJ mice. No untoward effects were seen in Al mice injected intravenously with 50 mu g/mouse daily for 10 days. There was a significant (P < 0.05) reduction in parasitemia and mortality by day 14 postinoculation(from 100% to 0%) in T. cruzi-infected AJ mice given 25 mu g of DC-1/mouse on days 2, 4, 6, 8, and 10 postinoculation.